PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,006 | +51.5% | 4,794 | +116.8% | 0.00% | – |
| Q2 2023 | $5,284 | – | 2,211 | +1562.4% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 133 | -92.6% | 0.00% | – |
| Q2 2022 | $5,000 | -16.7% | 1,807 | +126.2% | 0.00% | – |
| Q4 2021 | $6,000 | -60.0% | 799 | -48.4% | 0.00% | – |
| Q2 2021 | $15,000 | -44.4% | 1,548 | -10.4% | 0.00% | – |
| Q1 2021 | $27,000 | 0.0% | 1,728 | +54.0% | 0.00% | -100.0% |
| Q4 2020 | $27,000 | -12.9% | 1,122 | -38.6% | 0.00% | – |
| Q3 2020 | $31,000 | +933.3% | 1,828 | +1887.0% | 0.00% | – |
| Q2 2020 | $3,000 | – | 92 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $7,216,152 | 2.51% |
| Privium Fund Management (UK) Ltd | 119,730 | $320,876 | 0.24% |
| Ikarian Capital, LLC | 188,664 | $505,619 | 0.12% |
| Orbimed Advisors | 830,641 | $2,226,118 | 0.04% |
| Boxer Capital, LLC | 209,227 | $560,728 | 0.03% |
| Perceptive Advisors | 290,051 | $777,337 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $171,520 | 0.00% |
| Baker Brothers Advisors | 199,671 | $535,118 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $50,556 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 46,147 | $123,674 | 0.00% |